Selenoprotein P in Myocardial Infarction with Cardiogenic Shock.

BACKGROUND Reperfusion strategies in acute myocardial infarction (AMI) may result in ischemia reperfusion injury characterized by increased oxidative stress, inflammation and ultimately death of myocardial tissue which may be of particular importance in infarct-related cardiogenic shock (CS). Many anti-oxidative and immune regulatory processes depend on selenium which in large proportions is bound to circulating selenoprotein P (SelP). Individual SelP patterns may therefore be associated with inflammatory response and possibly mortality in patients with CS post AMI. METHODS In the randomized Intra-Aortic Balloon Pump in cardiogenic Shock II (IABP-SHOCK II)-trial, 600 patients with CS complicating AMI were assigned to therapy with or without IABP. In a predefined biomarker substudy of 147 patients, we analyzed SelP levels 1 and 3 days following randomization. Samples were compared to healthy controls and associations with the unspecific inflammatory marker C-reactive protein (CRP) were analyzed. RESULTS Compared with controls SelP levels in patients with infarct-related CS were markedly higher (2.7-fold at day 1 and 5.7-fold at day 3 following AMI, all p < 0.001). Thirty-day mortality was significantly higher in patients with SelP levels above the 75th percentile at day 3 following AMI (26% vs. 46%, p = 0.045). SelP was significantly proportionally correlated with CRP 1 (R = 0.762, p < 0.0001) and 3 days (R = 0.777 p < 0.0001) following AMI. CONCLUSIONS SelP levels are significantly increased post AMI with CS. Higher SelP levels are associated with increased CRP levels indicative for inflammatory processes. Future studies should focus on the characterization of SelP profiles following AMI and the identification of pathomechanisms affected by SelP.

[1]  M. Persson Moschos Selenoprotein P , 2020, Definitions.

[2]  U. Vogel,et al.  Genetic polymorphism in selenoprotein P modifies the response to selenium-rich foods on blood levels of selenium and selenoprotein P in a randomized dietary intervention study in Danes , 2018, Genes & Nutrition.

[3]  S. Kaneko,et al.  Endogenous Selenoprotein P, a Liver-Derived Secretory Protein, Mediates Myocardial Ischemia/Reperfusion Injury in Mice , 2018, International journal of molecular sciences.

[4]  Xiujun Li,et al.  The effect of selenium supplementation on coronary heart disease: A systematic review and meta-analysis of randomized controlled trials. , 2017, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[5]  G. Hardy,et al.  Selenium and Its Supplementation in Cardiovascular Disease—What do We Know? , 2015, Nutrients.

[6]  G. Schuler,et al.  Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: Design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. , 2015, American heart journal.

[7]  D. Panagiotakos,et al.  Gender-specific distribution of selenium to serum selenoproteins: associations with total selenium levels, age, smoking, body mass index, and physical activity. , 2014, BioFactors.

[8]  G. Schuler,et al.  Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial , 2013, The Lancet.

[9]  J. Joseph Selenium and Cardiometabolic Health: Inconclusive Yet Intriguing Evidence , 2013, The American journal of the medical sciences.

[10]  G. Schuler,et al.  Intraaortic balloon support for myocardial infarction with cardiogenic shock. , 2012, The New England journal of medicine.

[11]  Lisa E. Kilpatrick,et al.  Multiple forms of selenoprotein P in a candidate human plasma standard reference material. , 2012, Metallomics : integrated biometal science.

[12]  A. Macas,et al.  Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock. , 2011, Medicina.

[13]  J. Kukacka,et al.  Alterations in serum selenium levels and their relation to troponin I in acute myocardial infarction , 2010, Molecular and Cellular Biochemistry.

[14]  R. Burk,et al.  Selenoprotein P-expression, functions, and roles in mammals. , 2009, Biochimica et biophysica acta.

[15]  L. Duntas,et al.  Selenium and Inflammation: Underlying Anti-inflammatory Mechanisms , 2009, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[16]  S. Ahnve,et al.  IL-6 levels in acute and post myocardial infarction: their relation to CRP levels, infarction size, left ventricular systolic function, and heart failure. , 2004, European journal of internal medicine.

[17]  P. Palatini,et al.  C-reactive protein in acute myocardial infarction: association with heart failure. , 2003, American heart journal.

[18]  A. K. Motley,et al.  Selenoprotein metabolism and function: evidence for more than one function for selenoprotein P. , 2003, The Journal of nutrition.

[19]  E. Nartowicz,et al.  Increased plasma glutathione peroxidase activity in patients with acute myocardial infarction. , 2001, Medical science monitor : international medical journal of experimental and clinical research.

[20]  D. Littlejohn,et al.  Changes in the concentrations of plasma selenium and selenoproteins after minor elective surgery: further evidence for a negative acute phase response? , 1998, Clinical chemistry.